本页面由Tiger Trade Technology Pte. Ltd.提供服务

Sonnet BioTherapeutics Holdings, Inc.

1.26
0.0000
成交量:- -
成交额:- -
市值:891.81万
市盈率:-0.25
高:1.26
开:1.26
低:1.26
收:1.26
52周最高:5.95
52周最低:1.26
股本:707.79万
流通股本:680.21万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-5.0074
每股收益(LYR):-11.3504
净资产收益率:-310.85%
总资产收益率:-112.17%
市净率:0.83
市盈率(LYR):-0.11

数据加载中...

2023/07/17

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/07/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/06/30

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/30

重要事件披露

Form 8-K - Current report
2023/06/23

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/06/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/06/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/06/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/26

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/05/17

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/05/10

重要事件披露

8-K - Current report
2023/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/04/18

重要事件披露

8-K - Current report
2023/03/24

重要事件披露

8-K - Current report
2023/03/10

重要事件披露

8-K - Current report
2023/02/13

重要事件披露

8-K - Current report
2023/02/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/02/13

重要事件披露

8-K - Current report